The present invention comprises tetrazoloquinoline-compounds that are inhibitors of HCV. Compositions comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and compositions to inhibit HCV infection of a cell, particular in the form of treating HCV infection in a mammal.
本发明涉及
四唑喹啉类化合物,其为HCV
抑制剂。本发明还涉及将该化合物与药学上可接受的载体组合而成的组合物,以及使用该化合物和组合物抑制细胞的HCV感染的方法,特别是用于治疗哺乳动物的HCV感染。